Neuronal injury associated with HIV-1: Approaches to treatment

Annual Review of Pharmacology and Toxicology

Volumn 38, Issue , 1998, Pages 159-177

  Lipton, Stuart A ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Astrocytes; Free radicals; Macrophages; Nitric oxide; NMDA receptor

Indexed keywords

AMINE; ANTIRETROVIRUS AGENT; ARACHIDONIC ACID; CALCIUM; CYSTEINE; EXCITOTOXIN; FREE RADICAL; GLUTAMIC ACID; GLYCERYL TRINITRATE; GLYCOPROTEIN GP 120; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROTOXIN; NITRIC OXIDE; NUCLEOSIDE DERIVATIVE; PROTEINASE INHIBITOR; QUINOLINIC ACID; THROMBOCYTE ACTIVATING FACTOR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; ASTROCYTE; CALCIUM TRANSPORT; COGNITIVE DEFECT; DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; MICROGLIA; NERVE CELL LESION; NERVE CELL NECROSIS; PRIORITY JOURNAL; REVIEW; STROKE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0031748172     PISSN: 00664251     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.pharmtox.38.1.159     Document Type: Review

References (133)

1. Bacellar H, Mu-oz A, Miller EN, Cohen BA, Besley D, et al. 1994. Temporal trends in the incidence of HIV-1-related neurologic diseases: multicenter AIDS cohort study, 1985-1992. Neurology 44:1892-900
2. Lipton SA. 1994. Neurobiology: HIV displays its coat of arms. Nature 367: 113-14
3. Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, et al. 1988. The brain and AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 239:586-92
4. Budka H. 1991. Neuropathology of human immunodeficiency virus infection. Brain Pathol. 1:163-75
5. Ketzler S, Weis S, Haug H, Budka H. 1990. Loss of neurons in frontal cortex in AIDS brains. Acta Neuropathol. 80:90-92
6. Everall IP, Luthbert PJ, Lantos PL. 1991. Neuronal loss in the frontal cortex in HIV infection. Lancet 337:1119-21
7. Wiley CA, Masliah E, Morey M, Lemere C, DeTeresa RM, et al. 1991. Neocortical damage during HIV infection. Ann. Neurol. 29:651-7
8. Masliah E, Achim CL, Ge N, De-Teresa R, Terry RD, et al. 1992. Spectrum of human immunodeficiency virus-associated neocortical damage. Ann. Neurol. 32:321-29
9. Tenhula WN, Xu SZ, Madigan MC, Heller K, Freeman WR, et al. 1992. Morphometric comparisons of optic nerve axon loss in acquired immunodeficiency syndrome. Am. J. Ophthalmol. 113:14-20
10. Seilhean D, Duyckaerts C, Vazuex R, Bolgert F, Brunet P, et al. 1993. HIV-1-associated cognitive/motor complex: absence of neuronal loss in the cerebral neocortex. Neurology 43:1492-99
11. Koenig S, Gendelman HE, Orenstein JM, Dal Canto MC, Pozeshkpour GH, et al. 1986. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233:1089-93
12. Saito T, Sarer LR, Epstein LG, Michales J, Mintz M, et al. 1994. Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatrie central nervous tissues. Neurology 44:474-81
13. Tornatore C, Chandra R, Berger JR, Major EO. 1994. HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 44:481-87
14. Brenneman DE, Westbrook GL, Fitzgerald SP, Ennist DL, Elkins KL, et al. 1988. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 335:639-42
15. Dreyer EB, Kaiser PK, Offermann JT, Lipton SA. 1990. HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 248:364-67
16. Dreyer EB, Lipton SA. 1994. Tox ic neuronal effects of the HIV coat protein gp120 may be mediated through macrophage arachidonic acid. Soc. Neurosci. Abstr. 20:1049
17. Wahl LM, Corcoran ML, Pyle SW, Arthur LO, Harel-Bellan A, et al. 1989. Human immunodeficiency virus glyco-protein (gp 120) induction of monocyte arachidonic acid metabolites and interleukin 1. Proc. Natl. Acad. Sci. USA 86:621-25
18. Heyes MP, Brew BJ, Martin A, Price RW, Salazqr AM, et al. 1991. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann. Neurol. 29:202-9
19. Genis P, Jett M, Bernton EW, Boyle T, Gelbard HA, et al. 1992. Cytokines and arachidonic acid metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J. Exp. Med. 176:1703-18
20. Hayman M, Arbuthnott G, Harkiss G, Brace H, Filippi P, et al. 1993. Neurotoxicity of peptide analogies of the transactivating protein tat from Maedi-Visna virus and human immunodeficiency virus. Neuroscience 53:1-6
21. Toggas SM, Masliah E, Rockenstein EM, Rall GF, Abraham CR, et al. 1994. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367:188-93
22. Volterra A, Trotti D, Tromba C, Floridi S, Racagni G. 1994. Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J. Neurosci. 14:2924-32
23. Gelbard HA, Nottet HSLM, Swindells S, Jett M, Dzenko KA, et al. 1994. Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J. Virol. 68:4628-35
24. Bukrinsky MI, Nottet HSLM, Schmidtmayerova H, Dubrovsky L, Flanagan CR, et al. 1995. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J. Exp. Med. 181:735-45
25. Yeh MW, Nottet HLM, Gendelman HE, Lipton SA. 1994. HIV-1 coat protein gp120 stimulates human macrophages to release L-cysteine, an NMDA agonist. Soc. Neurosci. Abstr. 20:451
26. Giulian D, Vaca K, Noonan CA. 1990. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science 250:1593-96
27. Giulian D, Wendt E, Vaca K, Noonan CA. 1993. The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. Proc. Natl. Acad. Sci. USA 90:2769-73
28. Giulian D, Yu J, Li X, Tome D, Li J, et al. 1996. Study of receptor-mediated neurotoxins released by HIV-1-infected mononuclear phagocytes found in human brain. J. Neurosci. 16:3139-53
29. Lo T-M, Fallert CJ, Piser TM, Thayer SA. 1992. HIV-1 envelope protein evokes intracellular calcium oscillations in rat hippocampal neurons. Brain Res. 594:189-96
30. Lipton SA. 1992. Models of neuronal injury in AIDS: another role for the NMDA receptor? Trends Neurosci. 15:75-79
31. Diop AG, Lesort M, Esclaire F, Sindou P, Couratier P, et al. 1994. Tetrodotoxin blocks HIV coat protein (gp120) toxicity in primary neuronal cultures. Neurosci. Lett. 165:187-90
32. Savio T, Levi G. 1993. Neurotoxicity of HIV coat protein gp120, NMDA receptors, and protein kinase C: a study with rat cerebellar granule cell cultures. J. Neurosci. Res. 34:265-72
33. i homeostasis and induce neurotoxicty in human embryonic neurons. Eur. J. Neurosci. 7:2285-93
34. Lipton SA, Gendelman HE. 1995. The dementia associated with the acquired immunodeficiency syndrome. N. Engl. J. Med. 332:934-40
35. Benveniste H, Drejer J, Schousboe A, Diemer NH. 1984. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43:1369-74
36. Globus MY, Busto R, Dietrich WD, Martinez E, Valdes I, et al. 1988. Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis. J. Neurochem. 51:1455-64
37. Silverstein FS, Naik B, Simpson J. 1991. Hypoxia-ischemia stimulates hippocampal glutamate efflux in perinatal rat brain: an in vivo microdialysis study. Pediatr. Res. 30:587-90
38. Bustos G, Abarca J, Forray MI Gysling K, Bradberry CW, et al. 1992. Regulation of excitatory amino acid release by N-methyl-D-aspartate receptors in rat striatum: in vivo microdialysis studies. Brain Res. 585:105-15
39. Louzada JP, Dias JJ, Santos WF, Lachat JJ, Bradford HF, et al. 1992. Glutamate release in experimental ischaemia of the retina: an approach using microdialysis. J. Neurochem. 59:358-63
40. 1 ganglioside reduces ischemia-induced excitatory amino acid output: a microdialysis study in the gerbil hippocampus. Neurosci. Lett. 134:171-74
41. Person L, Hillered L. 1992. Chemical monitoring of neurosurgical intensive care patients using intracerebral microdialysis. J. Neurosurg. 76:72-80
42. Choi DW. 1988. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623-34
43. Meldrum B, Garthwaite J. 1990. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol. Sci. 11:379-87
44. Lipton SA, Rosenberg PA. 1994. Mechanisms of disease: excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330:613-22
45. Tyor WR, Glass JD, Griffin JW, Becker S, McArthur JC, et al. 1992. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann. Neurol. 31:349-60
46. Wesselingh SL, Power C, Glass JD, Tyor WR, McArthur JC, et al. 1993. Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann. Neurol. 33: 576-82
47. Griffin DE, Wesselingh SL, McArthur JC. 1994. Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia. Ann. Neurol. 35:592-97
48. Pulliam L, Herndler BG, Tang NM, McGrath MS. 1991. Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains. J. Clin. Invest. 87:503-12
49. Nottet HSLM, Jett M, Flanagan CR, Zhai Q-H, Persidsky Y, et al. 1995. A regulatory role for astrocytes in HIV-encephalitis: an overexpression of eicosanoids, platelet-activating factor and tumor necrosis factor-α by activated HIV-1-infected monocytes is attenuated by primary human astrocytes. J. Immunol. 154:3567-81
50. Selmaj KN, Farooq M, Norton T, Raine CS, Brosman CF. 1990. Proliferation of astrocytes in vitro in response to cytokines. J. Immunol. 144:129-35
51. Valone FH, Epstein LB. 1988. Biphasic platelet-activating factor synthesis by human monocytes stimulated with IL-β, tumor necrosis factor, or IFN-γ. J. Immunol. 141:3945-50
52. Heyes MP, Saito K, Markey SP. 1992. Human macrophages convert L-tryptophan to the neurotoxin quinolinic acid. Biochem. J. 283:633-35
53. 2+ currents in cultured sympathetic neurons. J. Neurosci. 12:2665-71
54. Simmons ML, Murphy S. 1993. Cytokines regulate L-arginine-dependent cyclic GMP production in rat glial cells. Eur. J. Neurosci. 5:825-31
55. Lipton SA, Kaiser PK, Sucher NJ, Dreyer EB, Offermann JT. 1990. AIDS virus coat protein sensitizes neurons to NMDA receptor-mediated toxicity. Soc. Neurosci. Abstr. 16:289
56. Lipton SA, Sucher NJ, Kaiser PK, Dreyer EB. 1991. Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron 7:111-18
57. Lipton SA. 1991. Calcium channel antagonists in the prevention of neurotoxicity. Adv. Pharmacol. 22:271-91
58. Lipton SA. 1992. Requirement for macrophages in neuronal injury induced by HIV envelope protein gp120. NeuroReport 3:913-15
59. Brenneman DE, Nicol T, Warren D, Bowers LM. 1990. Vasoactive intestinal peptide: a neurotrophic releasing agent and an astroglial mitogen. J. Neurosci. Res. 25:386-94
60. Benos DJ, Hahn BH, Bubien JK, Ghosh SK, Mashburn NA, et al. 1994. Envelope glycoprotein gp120 of human immunodeficiency virus type 1 alters ion transport in astrocytes: implications for AIDS dementia complex. Proc. Natl. Acad. Sci. USA 91:494-98
61. Dreyer E, Lipton SA. 1995. The coat protein gp120 of HIV-1 inhibits astrocyte uptake of excitatory amino acids via macrophage arachidonic acid. Eur. J. Neurosci. 7:2502-7
62. Harbour B, Szatkowski M, Ingledew N, Attwell D. 1989. Arachidonic acid induces a prolonged inhibition of glutamate uptake into glial cells. Nature 342:918-20
63. Volterra A, Trotti D, Cassutti P, Tromba C, Salvaggio A, et al. 1992. High sensitivity of glutamate uptake to extracellular free arachidonic acid levels in rat cortical synaptosomes and astrocytes. J. Neurochem. 59:600-6
64. Dawson VL, Dawson TM, Uhl GR, Snyder SH. 1993. Human immunodeficiency virus-1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc Natl. Acad. Sci. USA 90:3256-59
65. Miller B, Sarantis M, Traynelis SF, Attwell D. 1992. Potentiation of NMDA receptor currents by arachidonic acid. Nature 355:722-25
66. 65a. Vesce S, Bezzi P, Rossi D, Meldolesi J, Volterra A. 1997. HIV-1 gp120 glycoprotein affects the astrocyte control of extracellular glutamate by both inhibiting the uptake and stimulating the release of the amino acid. FEBS Lett. 411:107-9
67. Olney JW, Zorumski C, Price MT, Labryuere J. 1990. L-cysteine, abicarbonate-sensitive endogenous excitotoxin. Science 248:596-99
68. Lipton SA, Choi Y-B, Pan Z-H, Lei SZ, Chen H-SV, et al. 1993. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364:626-32
69. 2+ prevents neurotoxicity. Brain Res. 598:196-202
70. Adamson DC, Wildemann B, Sasaki M, Glass JD, McArthur JC, et al. 1996. Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 274:1917-21
71. Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA. 1995. Apoptosis and necrosis: two distinct events induced respectively by mild and intense insults with NMDA or nitric oxide/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. USA 92:7162-66
72. Ankarcrona M, Dypbukt JM, Bonfoco E, Ahivotovsky B, Orrenius S, et al. 1995. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15:961-73
73. Kerr JFR, Wyllie AH, Currie AR. 1972. Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetcis. Br. J. Cancer 26:239-57
74. Wyllie AH, Kerr JFR, Currie AR. 1980. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68:251-306
75. Duval E, Wyllie AH, Morris RG. 1985. Macrophage recognition of cells undergoing programmed cell death (apoptosis). Immunology 56:351-58
76. Savill JS, Fadok V, Henson P, Haslett C. 1993. Phagocyte recognition of cells undergoing apoptosis. Immunol. Today 14:131-36
77. Schwartz LM, Smith SW, Jones MEE, Osborne BA. 1993. Do all programmed cell deaths occur via apoptosis? Proc. Natl. Acad. Sci. USA 90:980-84
78. Linnik MD, Zobrist RH, Hatfield MD. 1993. Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats. Stroke 24:2002-8
79. Loo DT, Agata C, Pike CJ, Whittemore ER, Wulencewicz AJ, et al. 1993. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. USA 90:7951-55
80. MacManus JP, Buchan AM, Hill IE, Rasquinha I, Preston E. 1993. Global ischemia can cause DNA fragmentation indicative of apoptosis in rat brain. Neurosci. Lett. 159:89-92
81. MacManus TP, Hill IE, Huang Z-G, Rasquinha I, Xue D, et al. 1994. DNA damage consistent with apoptosis in transient focal ishemic neocortex. NeuroReport 5:493-96
82. Dessi F, Charriaut-Marlangue C, Khrestchatisky M, Ben-Ari Y. 1993. Glutamate induced neuronal death is not a programmed cell death in cerebellar cultures. J. Neurochem. 60:1953-55
83. Mitchell J, Lawson S, Moser B, Laidlaw SM, Cooper AJ, et al. 1994. Glutamate-induced apoptosis results in a loss of striatal neurons in the parkinsonian rat. Neuroscience 63:1-5
84. Pollard H, Cantagrel S, Charriau-Marlangue C, Moreau J, Ben-Ari Y. 1994. Apoptosis associated DNA fragmentation in epileptic brain damage. NeuroReport 5:1053-55
85. Pollard H, Charriaut-Marlangue C, Cantagrel S, Represa A, Robain O, et al. 1994. Kainate-induced apoptotic cell death in hippocampal neurons. Neuroscience 63:7-18
86. Behl C, Davis JB, Klier FG, Schubert D. 1994. Amyloid beta peptide induces necrosis rather than apoptosis. Brain Res. 665:253-64
87. Behl C, Davis JB, Lesley R, Schubert D. 1994. Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77:817-27
88. Filipkowski RK, Hetman M, Kaminska B, Kaczmarek L. 1994. DNA fragmentation in rat brain after intraperitoneal administration of kainate. NeuroReport 5:1538-40
89. Whittemore ER, Loo DT, Cotman CW. 1994. Exposure to hydrogen peroxide induces cell death via apoptosis in culture rat cortical neurons. NeuroReport 5:1485-88
90. Ratan RR, Murphy TH, Baraban JM. 1994. Macromolecular synthesis inhibitors prevent oxidative stress-induced apoptosis in embryonic cortical neurons by shunting cysteine from protein synthesis to glutathione. J. Neurosci. 14:4385-92
91. Harvey AR, Cui Q, Robertson D. 1994. The effect of cyclohexamide and ganglioside GM1 on the viability of retinotectally projecting ganglion cells following ablation of the superior colliculus in rats. Eur. J. Neurosci. 5:550-57
92. Petito CK, Roberts B. 1995. Evidence of apoptotic cell death in HIV encephalitis. Am. J. Pathol. 146:1121-30
93. Dickson DW. 1995. Apoptosis in the brain. Physiology and pathology. Am. J. Pathol. 146:1040-44
94. Dreyer EB, Zhang D, Lipton SA. 1995. Transciptional or translational inhibition blocks low dose NMDA-mediated cell death. NeuroReport 6:942-44
95. 93a. Ayata C, Ayata G, Hara H, Mathews RT, Beal MF, et al. 1997. Mechanisms of reduced striatal NMDA excitotoxicity in type 1 nitric oxide synthase knock-out mice. J. Neurosci. 17:6908-17
96. Bonfoco E, Ankarcrona M, Krainc D, Nicotera P, Lipton SA. 1997. Techniques for distinguishing apoptosis from necrosis in cerebrocortical and cerebellar neurons. In Neuromethods: Apoptosis Techniques and Protocols, ed. J Poirier, pp. 237-53. Totowa, NJ: Humana
97. Sidtis JJ, Gatsonis C, Price RW, Singer EJ, Collier AC, et al. 1993. Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. Ann. Neurol. 33:343-49
98. Lipton SA. 1997. Treating AIDS dementia. Science 276:1629-30
99. Lipton SA. 1993. Prospects for clinically tolerated NMDA antagonists: open-channel blockers and alternative redox states of nitric oxide. Trends Neurosci. 16:527-32
100. Lipton SA. 1992. Memantine prevents HIV coat protein-induced neuronal injury in vitro. Neurology 42:1403-5
101. Müller WEG, Schröder HC, Ushijima H, Dapper J, Bormann J. 1992. gp120 of HIV-1 induces apoptosis in rat cortical cell cultures: prevention by memantine. Eur. J. Pharmacol. 226:209-14
102. Lipton SA. 1992. 7-Chlorokynurenate ameliorates neuronal injury mediated by HIV envelope protein gp120 in retinal cultures. Eur. J. Neurosci. 4:1411-15
103. Lipton SA. 1993. Human immunodeficiency virus-infected macrophages, gp120, and N-methyl-D-aspartate receptor-mediated neurotoxicity. Ann. Neurol. 33:227-28
104. Chen H-SV, Pellegrini JW, Aggarwal SK, Lei SZ, Warach S, et al. 1992. Open-channel block of NMDA responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. J. Neurosci. 12:4427-36
105. Chen H-SV, Lipton SA. 1997. Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetititve antagonism. J. Physiol. 499:27-46
106. Seif el Nasr M, Perucher B, Rossberg C, Mennel H-D, Krieglstein J. 1990. Neuroprotective effect of memantine demonstrated in vivo and in vitro. Eur. J. Pharmacol. 185:19-24
107. Erdö SL, Schäfer M. 1991. Memantine is highly potent in protecting cortical cultures against excitotoxic cell death evoked by glutamate and N-methyl-D-aspartate. Eur. J. Pharmacol. 198:215-17
108. Keilhoff G, Wolf G. 1992. Memantine prevents quinolinic acid-induced hippocampal damage. Eur. J. Pharmacol. 219:451-54
109. Osborne NN, Quack G. 1992. Memantine stimulates inositol phosphates production in neurones and nullifies N-methyl-D-aspartate-induced destruction of retinal neurones. Neurochem. Int. 21:329-36
110. Pellegrini JW, Lipton SA. 1993. Delayed administration of memantine prevents N-methyl-D-aspartate receptor-mediated neurotoxicity. Ann. Neurol. 33:403-7
111. Stieg PE, Sathi S, Alvarado SP, Jackson PS, Pellegrini JW, et al. 1993. Post-stroke neuroprotection by memantine minimally affects behavior and does not block LTP. Soc. Neurosci. Abstr. 19:1503
112. Lipton SA, Jensen FE. 1992. Memantine, a clinically-tolerated NMDA open-channel blocker, prevents HIV coat protein-induced neuronal injury in vitro and in vivo. Soc. Neurosci. Abstr. 18:757
113. Toggas SM, Masliah E, Mucke L. 1996. Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine. Brain Res. 706:303-7
114. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. 1990. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87:1620-24
115. Dawson VL, Dawson TM, London ED, Bredt DS, Snyder SH. 1991. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA 88:6368-71
116. Dawson VL, Dawson TM, Bartley DA, Uhl GR, Snyder SH. 1993. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J. Neurosci. 13:2651-61
117. Lipton SA, Stamler JS. 1994. Actions of redox-related congeners of nitric oxide at the NMDA receptor. Neuropharmacology 33:1229-33
118. Lei SZ, Pan Z-H, Aggarwal SK, Chen H-SV, Hartman J, et al. 1992. Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron 8:1087-99
119. Sathi S, Edgecomb P, Warach S, Manchester K, Donaghey T, et al. 1993. Chronic transdermal nitroglycerin (NTG) is neuroprotective in experimental rodent stroke models. Soc. Neurosci. Abstr. 19:849
120. 117a. Tenneti L, D'Emila DM, Lipton SA. 1997. Suppression of neuronal apoptosis by S-nitrosylation of caspases. Neurosci. Lett. In press
121. Sullivan JM, Traynelis SF, Chen H-SV, Escobar W, Heinemann SF, et al. 1994. Identification of two cysteine residues that are required for redox modulation of the NMDA subtype of glutamate receptor. Neuron 13:929-36
122. Kohr G, Eckardt S, Lüddens H, Monyer H, Seeburg PH. 1994. NMDA receptor channels: subunit-specific potentiation by reducing agents. Neuron 12:1031-40
123. Omerovic A, Chen S-J, Leonard JP, Kelso SR. 1995. Subunit-specific redox modulation of NMDA receptros expressed in Xenopus oocytes. J. Recept. Signal Transduction Res. 15:811-27
124. Lipton SA, Choi Y-B, Sucher NJ, Pan Z-H, Stamler JS. 1996. Redox state, NMDA receptors, and NO-related species. Trends Pharmacol. Sci. 17:186-87
125. Choi Y-B, Chen H-SV, Sucher NJ, Lipton SA. 1996. Redox modulatory site(s) of recombinant NMDA receptors: subunit composition and conformation. Soc. Neurosci. Abstr. 22:1761
126. Sucher NJ, Awobuluyi M, Choi Y-B, Lipton SA. 1996. NMDA receptors: from genes to channels. Trends Pharmacol. Sci. 17:348-55
127. Stamler JS, Toone EJ, Lipton SA, Sucher NJ. 1997. (S)NO signals: translocation, regulation, and a consensus motif. Neuron 18:691-96
128. Manzoni O, Prezean L, Marin P, Deshager S, Bockaert L, Fagni L. 1992. Nitric oxide-induced blockade of NMDA receptors. Neuron 8:653-62
129. Fagni L, Oliver M, Lafon-Cazol M, Bockaert J. 1995. Involvement of divalent ions in the nitric oxide-induced blockade of N-methyl-D-aspartate receptors in cerebellar granule cells. Mol. Pharmacol. 47:1239-47
130. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, et al. 1996. CC CKR5: a RNATES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272:1955-58
131. Choe CM, Farzan M, Sun Y, Sullivan N, Rollins B, et al. 1996. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135-48
132. Doranz BJ, Rucker J, Yi Y, Smyth RJ, Samson M, et al. 1996. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85:1149-58
133. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, et al. 1996. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667-73